首页> 美国卫生研究院文献>Journal of Applied Clinical Medical Physics >Comparison of an anthropomorphic PRESAGE® dosimeter and radiochromic film with a commercial radiation treatment planning system for breast IMRT: a feasibility study
【2h】

Comparison of an anthropomorphic PRESAGE® dosimeter and radiochromic film with a commercial radiation treatment planning system for breast IMRT: a feasibility study

机译:拟人化PRESAGE®剂量计和放射致变色胶片与用于乳房IMRT的商业放射治疗计划系统的比较:可行性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This work presents a comparison of an anthropomorphic PRESAGE® dosimeter and radiochromic film measurements with a commercial treatment planning system to determine the feasibility of PRESAGE® for 3D dosimetry in breast IMRT. An anthropomorphic PRESAGE® phantom was created in the shape of a breast phantom. A five‐field IMRT plan was generated with a commercially available treatment planning system and delivered to the PRESAGE® phantom. The anthropomorphic PRESAGE® was scanned with the Duke midsized optical CT scanner (DMOS‐RPC) and the OD distribution was converted to dose. Comparisons were performed between the dose distribution calculated with the Pinnacle3 treatment planning system, PRESAGE®, and EBT2 film measurements. DVHs, gamma maps, and line profiles were used to evaluate the agreement. Gamma map comparisons showed that Pinnacle3 agreed with PRESAGE® as greater than 95% of comparison points for the PTV passed a ±3%/±3mm criterion when the outer 8 mm of phantom data were discluded. Edge artifacts were observed in the optical CT reconstruction, from the surface to approximately 8 mm depth. These artifacts resulted in dose differences between Pinnacle3 and PRESAGE® of up to 5% between the surface and a depth of 8 mm and decreased with increasing depth in the phantom. Line profile comparisons between all three independent measurements yielded a maximum difference of 2% within the central 80% of the field width. For the breast IMRT plan studied, the Pinnacle3 calculations agreed with PRESAGE® measurements to within the ±3%/±3mm gamma criterion. This work demonstrates the feasibility of the PRESAGE® to be fashioned into anthropomorphic shape, and establishes the accuracy of Pinnacle3 for breast IMRT. Furthermore, these data have established the groundwork for future investigations into 3D dosimetry with more complex anthropomorphic phantoms.PACS number: 87.53.Jw, 87.55.D‐, 87.55.dk
机译:这项工作提出了拟人化的PRESAGE®剂量计和放射致变色膜测量值与商业治疗计划系统的比较,以确定PRESAGE®进行3D乳房IMRT剂量测定的可行性。拟人化的PRESAGE®幻影以乳腺幻影的形状创建。使用商业上可用的治疗计划系统生成了五场IMRT计划,并将其发送到PRESAGE®幻象中。用Duke中型光学CT扫描仪(DMOS-RPC)扫描拟人PRESAGE®,并将OD分布转换为剂量。比较了使用Pinnacle 3 治疗计划系统计算的剂量分布,PRESAGE®和EBT2膜的测量结果。 DVH,伽玛图和线轮廓用于评估协议。伽玛图比较显示Pinnacle 3 与PRESAGE®一致,因为PTV的比较点的95%以上通过了 ± 3 / ± 3 mm 准则时,幻象数据的外部8 mm被驱散了。在光学CT重建过程中,从表面到大约8 mm的深度都观察到了边缘伪影。这些伪影导致Pinnacle 3 与PRESAGE®之间的表面和8 mm深度之间的剂量差异最大为5%,并且随着幻影深度的增加而减小。所有三个独立测量之间的线轮廓比较得出,在场宽的中心80%内最大差异为2%。对于所研究的乳房IMRT计划,Pinnacle 3 计算与PRESAGE®测量结果一致,且在 ± 3 / ± 3 mm 伽玛准则。这项工作证明了将PRESAGE®制成拟人化形状的可行性,并确定了Pinnacle 3 对乳房IMRT的准确性。此外,这些数据为将来使用更复杂的拟人化体模进行3D剂量学研究奠定了基础.PACS编号:87.53.Jw,87.55.D-,87.55.dk

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号